Generally, 95% of CML patients displaygenetic abnormality in the form of chromosomaltranslocation, i.e., Ph+ [t(9;22)], which causes theformation of the fusion oncogene BCR-ABL. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.